Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression

Stopped Difficulty recruiting participants because principal investigator noticed that the participants in the population were responding well to low doses of mood stabilizers and therefor would not be recruited into the study.

Conditions

• Bipolar Disorder
• Postpartum Depression

Interventions

• DRUG: Celecoxib
• DRUG: Placebo

Sponsor

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's